Healthcare
AI healthcare market forecasts point to rapid expansion
A market report describes rapid growth in AI healthcare applications spanning diagnostics, drug discovery, and intelligent medical technology, with forecasts reaching as high as $1.03 trillion by 2034.
A healthcare industry report says artificial intelligence is being applied across diagnostics, drug discovery, and intelligent medical technology. It cites estimates that the global AI healthcare market was worth $39.34 billion in 2025 and could reach $56.01 billion in 2026, with one forecast projecting approximately $1.03 trillion by 2034. Another estimate cited in the report projects the market could reach $505.59 billion by 2033, with a 38.9% annual growth rate from 2025 through 2033. The report presents these figures as market forecasts rather than measured healthcare outcomes. The practical trend it highlights is the expansion of AI beyond experimental research into commercial healthcare applications, including automated diagnostics, technology-assisted drug development, and intelligent medical devices. The scale of the projections suggests that healthcare providers, pharmaceutical companies, medical-device manufacturers, and technology firms are treating AI as a major investment category. However, the source is a market analysis and does not provide a single new clinical deployment or product with patient-level results. Its relevance is therefore industry-wide: it quantifies expectations for continued investment in healthcare AI and the technologies supporting diagnosis, treatment development, and care delivery.
Original source: GlobeNewswire